Lineage Cell Therapeutics, Inc. Accrued Bonuses, Current
Lineage Cell Therapeutics, Inc. (LCTX) had Accrued Bonuses, Current of $1.55 million as of 2016-09-30, per its 10-Q filed 2016-11-04.
Discontinued › Notes › Accrued Liabilities, Current
us-gaap:AccruedBonusesCurrent · last filed 2016-11-04
- 2016-09-30: Accrued Bonuses, Current $1.55M.
- 2016-06-30: Accrued Bonuses, Current $827.00K.
- 2016-03-31: Accrued Bonuses, Current $809.00K.
- 2015-12-31: Accrued Bonuses, Current $1.13M.
| Period end | Accrued Bonuses, Current | Accrued Bonuses, Current as first filed |
|---|---|---|
| 2016-09-30 | $1.55M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $827.00K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $809.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $1.13M 10-Q · filed 2016-11-04 | |
| 2015-09-30 | $804.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $548.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $240.69K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $964.00K 10-K · filed 2016-03-15 | $964.19K 10-K · filed 2015-03-11 |
| 2014-09-30 | $310.88K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $207.25K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $229.91K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $600.00K 10-K · filed 2015-03-11 | |
| 2013-09-30 | $250.00K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $497.84K 10-K · filed 2014-03-17 | |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-09 | |
| 2011-12-31 | $583.62K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |